Voloridge Investment Management, LLC Arcus Biosciences, Inc. Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$17.62 - $23.54 $408,008 - $545,092	23,156 New	23,156 $415,000
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $203,750 - $263,743	8,771 New	8,771 $229,000
Q1 2022 May 16, 2022	SELL	$28.92 - $41.83 $2.75 Million - $3.97 Million	-94,938 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$31.38 - $48.47 $2.98 Million - $4.6 Million	94,938 New	94,938 $3.84 Million
Q3 2020 Nov 16, 2020	SELL	$17.14 - $25.47 $239,308 - $355,612	-13,962 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $195,049 - $510,450	13,962 New	13,962 $345,000

200

51.5M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.02B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.